Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03489525
Title MEDI2228 in Subjects With Relapsed/Refractory Multiple Myeloma (MEDI2228)
Acronym MEDI2228
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors MedImmune LLC
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | GRC | ESP | AUS

Facility Status City State Zip Country Details
Research Site Phoenix Arizona 85054 United States Details
Research Site Jacksonville Florida 32224 United States Details
Research Site Boston Massachusetts 02114 United States Details
Research Site Boston Massachusetts 02215 United States Details
Research Site Detroit Michigan 48201 United States Details
Research Site Rochester Minnesota 55905 United States Details
Research Site Charlotte North Carolina 28204 United States Details
Research Site Fairfax Virginia 22031 United States Details
Research Site Melbourne 3004 Australia Details
Research Site Athens 11528 Greece Details
Research Site Badalona 08916 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field